Xiangyang Liu
-
- Diabetes Treatment and Management 6
- Diabetes Management and Research 2
- Nephrology top 10%
- Surgery top 10%
- Esophageal Cancer Research and Treatment 6
- Pancreatic function and diabetes 3
-
- Lung Cancer Diagnosis and Treatment 11
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Treatments and Mutations 4
-
- Metabolism, Diabetes, and Cancer 6
- Journals
- Nature Communications (1 paper)Radiotherapy and Oncology (1 paper)Clinical Science (1 paper)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Xiangyang Liu
33 papers receiving 759 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 360
- Cardiology and Cardiovascular Medicine 249
- Nephrology 48
- Surgery 296
- Pulmonary and Respiratory Medicine 157
Countries citing papers authored by Xiangyang Liu
This map shows the geographic impact of Xiangyang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Liu more than expected).
Fields of papers citing papers by Xiangyang Liu
This network shows the impact of papers produced by Xiangyang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Liu. The network helps show where Xiangyang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangyang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 5 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 13 | |
| 6 | 2019 | 85 | |
| 7 | 2019 | 17 | |
| 8 | SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heartbreakdown → | 2019 | 442 |
| 9 | 2018 | 13 | |
| 10 | 2018 | 25 | |
| 11 | 2017 | 32 | |
| 12 | 2017 | 41 | |
| 13 | 2015 | 1 | |
| 14 | 2015 | 3 | |
| 15 | [Correlation factors of lymph node metastasis in patients with clinical stage T1a non-small cell lung cancer]. | 2015 | 1 |
| 16 | 2014 | 2 | |
| 17 | 2014 | 0 | |
| 18 | 2013 | 3 | |
| 19 | 2012 | 7 | |
| 20 | Risk factors for mortality and major morbidity after lung cancer surgery in elderly patients aged 70 years and over | 2006 | 1 |
About Xiangyang Liu
Xiangyang Liu is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Physiology, having authored 34 papers that have together received 770 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (11 papers), Esophageal Cancer Research and Treatment (6 papers), Metabolism, Diabetes, and Cancer (6 papers), Diabetes Treatment and Management (6 papers), Gastric Cancer Management and Outcomes (4 papers), Lung Cancer Treatments and Mutations (4 papers), Pancreatic function and diabetes (3 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (360 citations), Cardiology and Cardiovascular Medicine (249 citations) and Nephrology (48 citations). Xiangyang Liu has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Liming Chen, Linxin Xu, Bei Sun, Mei Xue, Xiaochen Yu, Yunhong Lu, Ying Cheng, Fei Han, Jie Zhang and Ting Li. Their work appears in journals such as Nature Communications, Radiotherapy and Oncology and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.